Home > Financial Ratios > BROOKS LABORATORIES

BROOKS LABORATORIES
Core EBITDA Margin

    Back to All Ratios
BROOKS LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BROOKS LABORATORIES
Please provide your vote to see the results

BROOKS LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 1.623.86-41.80-15.630.67

What is the latest Core EBITDA Margin ratio of BROOKS LABORATORIES ?

The latest Core EBITDA Margin ratio of BROOKS LABORATORIES is 1.62 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar20251.62
Mar20243.86
Mar2023-41.80
Mar2022-15.63
Mar20210.67

How is Core EBITDA Margin of BROOKS LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2025 1.62
-58.03
Mar2024 3.86
Positive
Mar2023 -41.8
Negative
Mar2022 -15.63
Negative
Mar2021 0.67 -

Other Financial Ratios of BROOKS LABORATORIES


Compare Core EBITDA Margin ratio of peers of BROOKS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BROOKS LABORATORIES ₹200.6 Cr -5.9% 16.9% -43.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,937.0 Cr 1.2% -7% 2.5% Stock Analytics
DIVIS LABORATORIES ₹165,359.0 Cr 1.8% 2.7% 17% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,431.0 Cr 0.5% -4.8% 32.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,114.0 Cr 0.3% -4.5% 11.5% Stock Analytics
CIPLA ₹100,028.0 Cr 0.7% -5.8% -13.1% Stock Analytics


BROOKS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BROOKS LABORATORIES

-5.9%

16.9%

-43.3%

SENSEX

2.4%

3.2%

5.8%


You may also like the below Video Courses